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The  increasing  requirement  for  multivalent  vaccines  containing  diverse  capsular  polysaccharides  has
created  an unmet  need  for  a fast  and  straightforward  assay  for polysaccharide  titer.  We  describe  a
novel  and  robust  assay  for the  quantitation  of anionic  capsular  polysaccharides.  The  binding  of  hex-
adecyltrimethyammonium  bromide  (Hb)  to anionic  capsular  polysaccharides  results  in  a precipitation
reaction  wherein  the  suspension  turbidity  is proportional  to  polysaccharide  titer.  The  turbidity  can  be
quickly  measured  as  absorbance  across  a range  of  wavelengths  that  resolve  scattering  light. Carbohy-
drates  comprised  of repeating  units  of  one  to seven  monosaccharides  with  phosphodiester  groups,  uronic
acids,  and  sialic  acids  all reacted  strongly  and there  does  not  appear  to be speciﬁcity  with  respect  to  the
particular  anionic  moiety.  The  assay  is compatible  with  an  array  of  common  buffers  across  a  pH range
of  3.0–8.75  and  with  NaCl  concentration  exceeding  400  mM.  Interference  from  DNA  can  be eliminated
with  a  short  incubation  step  with  DNase.  With  these treatments,  the  assay  has  been  employed  in  samples
as  complex  as fermentation  broth.  A two-log  dynamic  range  has  been  established  with  a  mean  relative
standard  deviation  less  than  10%  across  this  range  although  inferior  performance  has  been  observed  in
fermentation  broth.
The precipitation  assay  enables  the  rapid  quantitation  of  anionic  polysaccharides.  The  resulting  pro-
cedure  can  robustly  measure  the  titer  of  myriad  anionic  capsular  polysaccharides  (CPS)  in 96 samples  in
less  than  30  min  using  low  toxicity  reagents  and  routine  laboratory  equipment.  This development  will
greatly  reduce  the effort  required  to  measure  polysaccharide  titer  and  yield  during  process  development
s.of  polysaccharide  vaccineAbbreviations: Hb, hexadecyltrimethylammonium bromide; CPS, capsular
olysaccharide;  HTPD, high throughput process development; Mn  C, meningococ-
al  serotype C capsular polysaccharide; Mn Y, meningococcal serotype Y capsular
olysaccharide;  I, ionic strength; CMC, critical micelle concentration; RSD, relative
tandard deviation.
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1. Introduction
Polysaccharide conjugate vaccines are comprised of one or more
distinct capsular polysaccharides (CPS) covalently linked to a car-
rier, often an immunogenic protein. Manufacturing processes for
multivalent polysaccharide vaccines are complex and expensive.
Several different fermentation and puriﬁcation processes must be
developed and operated to produce CPS material for a single vaccine
product. The evolution of high throughput process development
(HTPD) for CPS vaccines has been impeded by the lack of rapid
assays for CPS quantitation. The challenge in designing streamlined
titer assays lies in the intrinsic complexity of CPS. Owing to this con-
straint, the historical set of CPS titer assays is comprised of complex
procedures speciﬁc for a given structural moiety/repeating unit.
Open access under CC BY license.1.1.  Capsular polysaccharide biology
Capsular polysaccharides form the outer layer of bacte-
rial cell envelopes. These heterogeneous polymers exhibit vast
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tructural diversity but are generally composed of monosaccharide
nits joined through glycosidic and phosphodiester bonds into
epeating oligosaccharide units [1]. Native CPS are composed of
ens to thousands of oligosaccharide repeat units linked together
ith molecular weights (MW)  ranging from kilodalton (kDa) to
egadalton (MDa). The underlying oligosaccharide repeat unit
an be speciﬁc to a particular bacterial species, to differentiated
erotypes within a species, or to structurally differentiated strains
2]. While the particular constitutional monosaccharide units are
ften conserved within a species, the oligosaccharide structure can
iffer markedly. In addition, due to the large number of hydroxyls
n each oligosaccharide, covalent bonds and O-acetylation can
orm at an array of locations, resulting in a highly complex and
ariable macromolecular structure.
.2. Carbohydrate titer assays
The published assays for capsular polysaccharides are diverse
nd typically involve complex procedures. Many different classes
f assays have been utilized to quantify saccharide content, includ-
ng ELISA, liquid and gas chromatography, ﬂuorescence, infrared
pectroscopy, capillary electrophoresis, mass spectrometry and
olorimetry [3–16]. Refractive index has been used in conjunction
ith HPLC for many years to estimate sugar content. How-
ver, without the added puriﬁcation and normalization provided
y time-consuming chromatography, this approach has proven
xceedingly sensitive to chemical, thermal, and hydraulic inter-
erence [17–19]. Due to the ubiquity of spectrophotometers and
elative simplicity of the measurement, colorimetric assays have
emained popular and include assays based on phenol sulfuric acid
or hexoses/pentoses, anthrone for hexoses/pentoses, resorcinol for
ialic acid, ascorbic acid for phosphates, and purpald for glycols
3,20–23]. Other methods involving phenol, 1-napthosulfonate,
nd  aniline phthalate/TCA have been proposed but suffer from tox-
city, interference, and limited reactivity with ketoses, respectively
22]. All of the aforementioned methods suffer from a combina-
ion of large sample requirements, complex sample preparations
nd derivatizations, highly toxic chemicals, low throughput, insuf-
ciently broad reactivity and substantial interference.
Several authors have recognized the analytical bottleneck posed
y sugar quantitation and devised high throughput methods. Pro-
edures based on anthrone, phenol sulfuric acid, and purpald have
een scaled-down to microplates [24–26]. However, these assays
ossess many of the same weaknesses as the original progenitor
ssays such as reagent instability, poor reactivity and undesirable
andling of highly toxic reagents. A simple, fast, high throughput
nd near-universal method for determining polysaccharide quan-
ity would streamline process development for CPS and facilitate
TPD for multivalent vaccines.
.3. Cationic surfactants and phase separation
The cationic detergent, hexadecyltrimethylammonium bromide
Hb) has been used in multiple applications. For puriﬁcation, Hb
as been shown to improve glycoprotein resolution in gel elec-
rophoresis and to facilitate DNA precipitation [27]. Hb has also
een cited extensively as a precipitation agent for the puriﬁcation
f CPS [28–32]. However, to the best of our knowledge, the interac-
ion of Hb with anionic polysaccharides has never been exploited
nalytically for the purpose of quantifying polysaccharide content.
The interactions between Hb and polyelectrolytes have been
tudied extensively [33–40]. The binding of Hb to polyanions
s an entropically driven process, principally mediated by elec-
rostatic interactions via charge effect neutralization [35,38,40].
rocedurally, as the Hb concentration is increased past the critical
icelle concentration (CMC) towards saturation, free charge (2013) 5659– 5665
on  the polyanionic CPS is neutralized, resulting in precipitation
and continued aggregation until particulates of sufﬁcient size to
scatter light are formed [33]. Hydrophobic interactions between
the surfactant tail and uncharged regions of the polymer can also
be signiﬁcant, particularly at pH < 3 but are usually secondary to
charge–charge interactions [37,40–43].
In this paper, we  describe the development and testing of a
quantitative assay for CPS titer based on the precipitation of an
anionic capsular polysaccharide with a cationic detergent. Accu-
racy, precision, robustness, sample matrix interference, sample
conditioning, and universality of reaction are described using CPS
derived from a variety of bacterial species.
2. Materials and methods
2.1.  Materials
All  common chemicals were commercial analytical grade. Hex-
adecyltrimethylammonium bromide, bovine serum albumin and
protease from S. griseus were purchased from Sigma. Deoxyribonu-
cleic acid (DNA) from salmon sperm came from Fisher Scientiﬁc
(Pittsburgh, PA). Amresco (Solon, OH) provided DNase I (ultra pure
grade), trypsin (USP grade), and proteinase K (biotechnology grade)
enzymes. Merck KGaA (Darmstadt, Germany) supplied Benzonase.
0.22 m polyethersulfone or cellulose acetate ﬁlters were used
interchangeably to sterile ﬁlter buffer solutions (Millipore, Biller-
ica, MA). Biological solutions (enzymes, proteins, DNA) were not
ﬁltered. 96-well, desalting microplates (G-25, 500 L) were pur-
chased from GE Healthcare (Uppsala, Sweden). Acrylic microplates
(Costar 3635) from Corning were used (Corning, NY) for all UV
measurements.
Capsular polysaccharides from various serotypes of S. pneumo-
niae, S. aureus, and N. meningitidis were kindly provided by Pﬁzer
R&D. All sugars have D and  structural conﬁguration. CPS were
sterile ﬁltered as part of their respective manufacturing process
but were not ﬁltered after receipt from manufacturing. The titers
of stock solutions of S. pneumoniae and S. aureus CPS were derived
from SOP-based serotype-speciﬁc SEC-RI assays of process inter-
mediate and puriﬁed drug substance stock obtained from Pﬁzer
manufacturing. For N. meningitidis CPS, the titers of stock solutions
were derived from a SOP-based colorimetric assay employing the
reaction of 4-(dimethylamino) benzaldehyde with N-acetyl neu-
raminic acid under acidic conditions. For all serotypes, dilutions
were performed with 25 mM sodium phosphate, pH 7.2.
2.2. Desalting
Desalting plates were equilibrated with 25 mM sodium phos-
phate, pH 7.2 according to the manufacturer’s instructions. 130 L
of sample was added to the center of the top of each bed in the
desalting microplate. Centrifugation at 700 × g relative centrifugal
force (RCF) for 2 min  was  sufﬁcient to elute the conditioned sample.
2.3. Hb phase separation assay
100 L of desalted (except where noted) capsular polysaccha-
ride sample was  dispensed into each well of a 96-well acrylic
microplate. 100 mM of Hb was  dissolved in 25 mM sodium phos-
phate, pH 7.2 at 37 ◦C before 100 L of 100 mM Hb was  dispensed
into each well. Five cycles of slow pipettor aspiration/dispensing
were executed immediately upon addition of Hb reagent to effect
the requisite mixing. Care was taken to ensure that no air was
evacuated from the tip or expelled into any microwell. Following
15 min  of incubation at room temperature, absorbance values were
read at 320 nm using a spectrophotometric plate reader (Molec-
ular Devices, Spectramax M3)  with well height compensation
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he  standard assay procedure, samples were batch-desalted. b shows the log trans
 = 0.37 ln(x) + 1.27, R2 = 0.99; Mn Y: y = 0.30 ln(x) + 1.27, R2 = 0.96.
isabled. Permutations on the aforementioned standard method
re described in the relevant Results section.
.4. Enzymatic treatments
Proteinase  K, trypsin, and S. griseus proteases were dissolved
n separate 1 mL  aliquots of 25 mM sodium phosphate, pH 7.2 to
chieve activity of 200 units/mL for each protease. DNase I and Ben-
onase were separately formulated in 25 mM MgCl2, 5 mM CaCl2,
5 mM sodium phosphate, pH 7.2 to a concentration of 3000 Kunitz
ctivity units. 10% (v/v) of the appropriate enzyme solution was
dded to each sample. Treated samples were then incubated for
 h at 37 ◦C prior to the execution of the standard assay method.
n parallel with treated samples, negative controls were incubated
ith the respective enzyme-free sample buffer.
. Results and discussion
Two  anionic serogroups from N. meningitidis were used to
eﬁne the operating parameters for the phase separation assay.
erogroup C (Mn  C) is comprised of a repeating unit of (2,9)N-
cetylneuraminic acid with two sites possessing nearly 100%
-acetylation [44]. Serogroup Y (Mn  Y) consists of repeating units
f (4)N-acetylneuraminic acid (2→6)-glucose-(1→ with two sites
ossessing O-acetylation occupancy of approximately 50% [44].hase separation assay for Mn C and Mn Y. Initial [NaCl] = 10–400 mM NaCl. As per
d concentration values on the x-axis, deﬁnied by the following equations: Mn  C:
Due  to the neuraminic acid, each CPS has one anion (i.e. carboxylic
acid) per repeating unit.
Mn C and Mn  Y were serially diluted into 25 mM sodium phos-
phate, pH 7.2 in the presence of 10, 50, 100, 200, 300, or 400 mM
NaCl in the background buffer. The range and precision of the phase
separation assay were determined by measuring the light scatter-
ing without correction for blanks or negative controls (Fig. 1). The
data for each CPS concentration (with varying [NaCl]) was  averaged.
The assay provided a dynamic range of approximately 2 logs,
spanning the 0.016–1.28 mg/mL range. Across this working range
of Mn  C, a linear regression analysis of the logarithmically trans-
formed data yielded a correlation coefﬁcient (R2) of 0.99 and a mean
relative standard deviation (RSD) of 2.6%. For Mn Y, R2 = 0.96 with a
mean RSD of 3.6%. Mn  Y exhibited a lower reactivity than the Mn  C,
resulting in a reduced sensitivity for dilute sample but a potentially
increased upper limit of quantitation (LOQ). The reduced charge
density of Mn  Y is thought to underpin the contrasting reactivity
with Mn  C.
3.1.  Robustness3.1.1. Operational parameters
Absorbance  at wavelengths of 320, 405, and 600 nm was exam-
ined (data not shown). A similar mean precision was  observed for
each wavelength but the sensitivity was  inversely proportional to
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Fig. 3. Reactivity of bacterial CPS from S. pneumoniae and S. aureus in the precipita-
tion  assay. Puriﬁed CPS were serially diluted in 25 mM sodium phosphate, pH 7.2.
Each line represents a distinct anionic CPS, except for serotype 7F, which is neutral.
The pneumococcal polysaccharides are comprised of linear repeating units exceptn  25 mM sodium phosphate, pH 7.2 No difference was detected whether Hb was
issolved in 25 mM sodium phosphate, pH 7.2 or reverse osmosis-puriﬁed water.
he legend indicates the concentration of Mn C in mM,  corresponding to 0.64, 0.32,
nd 0.16 mg/mL. A 20-fold range of Hb:CPS ratios was  examined.
avelength. In order to achieve improved accuracy at a low LOQ,
20 nm was selected for the standard procedure. For circumstances
here an elevated upper LOQ is desired or where background sub-
tances interfere, longer wavelengths can be utilized.
A  total reaction volume of 200 L was selected to ensure that
he CPS concentrations measured at the upper LOQ (i.e. 2 AU) were
lose to the expected concentrations present in process samples.
he total reaction volume per well can be increased to 300 L to
ncrease the sensitivity or reduced using half area microplates to
onserve sample. The number of aspiration cycles employed to mix
he samples was found to have a minor effect on precision, with 5
ycles found to be more precise than 8 cycles, particularly for more
oncentrated samples.
The  addition of the Hb reagent to a solution containing Mn
 initiated a dynamic precipitation reaction that matured over a
6 h interval. While the extent of reaction was nearly complete in
he ﬁrst few seconds following addition, low starting concentra-
ions of CPS kinetically limited the reaction. Therefore, the result
f immediate measurement was inferior sensitivity and greater
mprecision. To address this issue, a minimum precipitation devel-
pment time of 15 min  is recommended. After 15 min  and before
pproximately two hours, very precise and accurate titer measure-
ents can be made spectrometrically (RSD ≤5%). If the precipitate
s allowed to continue to mature, the smaller particulates gradu-
lly ﬂocculate with other particulates and settle to the bottom of
he microwell. The result is attenuated light scattering, leading to a
educed signal range and inferior precision (RSD ≤10%). Resuspen-
ion of precipitate through orbital mixing of the microplate did not
ecover the signal range or precision.
.1.2. Reagent concentration
The  method is insensitive to the concentration of the Hb reagent
cross the 20–80 mM range (Fig. 2). From a 100 mM stock solution,
0 mM was speciﬁed as the concentration of diluted Hb in the ﬁnal
ssay mixture. The target concentration of Hb is well above its CMC
nd ensures a signiﬁcant molar excess of surfactant when incu-
ated with typical polysaccharide process concentrations. These
ttributes decrease the risk that inaccurate reagent formulation or
PS mass variability will signiﬁcantly skew the titer results..1.3.  Physicochemical effects
The principal interaction between the Hb and the CPS relies on
harge–charge interactions. Accordingly, the effect of ionic strengthfor serotypes 5, 7F, and 18C, which are branched. Figure b shows the log transformed
concentration  values on the x-axis.
([I]) on the precipitation reaction was  assessed (i.e. without batch-
desalting) and found to attenuate Mn  C and Mn  Y reactivity when
[I] ≥200 mM,  when NaCl was  the salt. When batch-desalted with
the prescribed gel ﬁltration microplate, the impact of [I] on precip-
itation was eliminated across a range of 10–400 mM NaCl (Fig. 1).
The meningococcal CPS recovery across the G-25 microplate was
greater than 95% with Mn  C or Mn  Y.
An ancillary beneﬁt of the desalting step is broad robustness
with respect to sample pH and buffer system. Buffers including
formate, imidazole, HEPES, tris, acetate, MES, and phosphate were
evaluated with buffer concentrations ranging from 25 to 100 mM
and pH from 3.0 to 8.75. No signiﬁcant interference was  noted
for any of these buffer systems or pH ranges, demonstrating the
chemical compatibility of this phase separation assay.
3.1.4.  Reactivity with bacterial species
A key assay property is the capacity to react modularly with
anionic capsular polysaccharides. Standard curves for CPS from
serogroups of S. pneumoniae and S. aureus were generated (Fig. 3).
The repeating units were linear or branched and contained from 2
to 7 monosaccharides [2]. The pneumococcal serotypes possessed
either sialic acids or phosphates in their side chain or backbone. The
staphylococcal CPS were both comprised of trisaccharide repeating
units with mannosaminuronic acids, differing only in the pattern
of linkages and O-acetylation [45]. Each anionic serotype reacted
monotonically in the assay. Linear regression analyses with each
serotype were characterized by R2 > 0.94, indicating precipitation
that was  consistently proportional to CPS titer.
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Although  samples were sterile-ﬁltered as part of the production process, no sample
conditioning besides the integrated batch-desalting step was implemented. b shows
the log transformed concentration values on the x-axis (for values ≥ 0.1 mg/mL),
deﬁned  by the following equations: CP8 Post-Clariﬁcation: y = 0.27 ln(x) + 0.79,
R2 = 0.99; CP8 Post-Primary Recovery: y = 0.31 ln(x) + 0.94, R2 = 0.99; CP8 Post-
Polishing:  y = 0.26 ln(x) + 0.81, R2 = 0.99; CP5 Post-Clariﬁcation: y = 0.24 ln(x) + 0.74,
R2 = 0.97; CP5 Post-Primary Recovery: y = 0.27 ln(x) + 0.78, R2 = 0.99; CP5 Post-ncubated at 37 ◦C for 1 h. ‘Mn  C Control’ was  composed of Mn  C (i.e. ‘No Treatment’)
piked  with the enzyme buffer absent the enzyme. The standard assay procedure
as  then followed.
Due to the variety of CPS structures, extensive efforts were
ade to correlate the signal intensity with myriad structural or
hemical properties of the CPS (Fig. 3). The only statistically sig-
iﬁcant (p < 0.1 level) correlation (positive) with turbidity existed
or the charge density of sugar. This ﬁnding is corroborated by
esearch showing the higher charge density increases the coop-
rativity of binding between Hb and polyanions [34]. High charge
ensity may  mitigate the impact of [I], with polyanions of increased
harge density binding to Hb with greater resiliency to elevated
I]. Indeed, a decreased dependency to increased [I] was observed
or Mn  C relative to Mn  Y, which has a lower charge density (data
ot shown). A single neutral CPS was included in the reactivity
tudy and exhibited negligible reaction with Hb, except for a slight
endency to precipitate at higher concentrations (Fig. 4), possibly
hrough hydrophobic interactions with the aliphatic tail domain of
b [46].
.2. Interference from impurities
The  most prevalent non-CPS polyanions in bacterial processes
re nucleic acids. DNA is frequently released by dying cells, by
ell lysis during clariﬁcation operations following CPS extrac-
ions, and in some cases, by intentional cell lysis to liberate CPS
29,47–49]. DNA titers can be above 1 mg/mL  in samples taken
rom downstream processes (personal communication from Dr.
ernie Violand and Dr. Khurram Sunasara, Pﬁzer R&D). Because of
he high levels of DNA in the downstream process and the cor-
esponding documented interference, enzymatic digestions were
xplored to mitigate DNA-related interference. In isolation, as lit-
le as 0.02 mg/mL  DNA was found to signal in the assay (data not
hown). In the presence of Mn  C (>0.1 mg/mL), >0.2 mg/mL  DNA
as required for interference, suggesting a competitive effect.
Deoxyribonuclease I (DNase I) and Benzonase are Mg2+-
ependent endonucleases that cleave single and double stranded
NA into small oligonucleotides [49,50]. We  hypothesized that by
dding endonucleases to a CPS sample at the outset of the assay, the
NA would be cleaved into small fragments. The small fragments
ould then be removed with the batch-desalting step.
Fig.  4 illustrates the efﬁcacy of enzymatic sample condition-
ng in eliminating nucleic acid interference in the phase separationPolishing:  y = 0.22 ln(x) + 0.67, R2 = 0.98; Polynomial ﬁts could be employed to extend
the  range of the standard curve.
assay. Both DNase I and Benzonase were highly effective in elimi-
nating the signal from DNA. The negligible difference between the
endonuclease-treated samples and the control proves the utility of
this sample conditioning method for removing nucleic acid inter-
ference.
Following clariﬁcation, proteins can also be present in high
concentrations. When evaluated, basic model proteins did not
react and acidic proteins reacted mildly when concentrations
approached 8 g/L, a value exceeding typical process values. Experi-
mentation similar to the endonucleases work was performed with
proteases (i.e. trypsin, proteinase K, and protease from S. griseus).
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Fig. 6. Enhancement in assay performance with DNase treatment. Pneumococcal
serotype  6B was  serially diluted in 25 mM sodium phosphate, pH 7.2. Fermentation
broth  was centrifuged and sterile ﬁltered prior to the addition of 6B. The sample
was  then diluted with 25 mM sodium phosphate, pH 7.2 to attain a 2-fold dilution.
A 50% solution of broth with negligible amounts of CPS was characterized by an
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wample for 1 h at 37 C with 300 Kunitz units/mL of Benzonase prior to execution of
he standard assay procedure. Linear regression analysis was performed and the log
lopes for the three sample sets were 0.089, 0.20, and 0.26.
nly proteinase K exhibited effectiveness in reducing interference
data not shown).
.3.  Complex in-process samples
.3.1. Polishing unit operations
To  assess the compatibility of the assay with downstream
rocessing, samples were taken at several points in a puriﬁcation
rain for staphylococcal CPS (Fig. 5). The results from two distinct
uriﬁcation processes suggest that the phase separation assay can
e deployed at various points in a downstream process and cope
ith complex sample matrices.
.3.2. Fermentation broth
The most challenging sample background for assay deploy-
ent is fermentation broth. In addition to proteins and DNA, high
oncentrations of endotoxin, metabolites, growth media, and cell
omponents are among the components in the fermentation milieu.
entrifuged fermentation broth from pneumococcal serotype 6B
as screened for its impact on precipitation assay performance
Fig. 6).
With DNase digestion, the signal from clariﬁed fermentation
roth was reduced approximately 50%, from 1.4 AU to 0.7 AU. The
ecrease in interference improved the slope of the 6B standard
urve from 34% to nearly 80% of the reference slope. Across the
.1–1.0 mg/ml  6B range, the curves of the standard and the DNase-
reated samples were approximately parallel. This result differs
rom the 0.01–0.1 mg/ml  6B range, highlighting the dependency
f the interference on CPS concentration.
It is challenging to eliminate all the interfering substances in
lariﬁed fermentation broth. Moreover, the composition of broth
s highly dynamic, making it difﬁcult for an analyst to assure com-
lete removal of matrix inhibition or to have high conﬁdence in
he accuracy of the results for a new fermentation batch. In many
ases, the beneﬁt of this type of exhaustive work would not jus-
ify the investment. However, as depicted in Fig. 6, even in broth
ith no enzymatic pre-treatment, the assay response is monotonic (2013) 5659– 5665
with  sample concentration. The implication is minimally, the phase
separation assay will accurately provide relative measurements of
CPS where the sample background is comparable. This property is
important for measurements of batch–batch consistency and par-
ticularly useful to scientists working in HTPD, where frequently the
key aim is to identify rapidly the best subset of experimental com-
binations on a microplate, for more meticulous development for
future scale-up.
4.  Conclusion
In this report, we  have described the development, characteri-
zation, and qualiﬁcation of a novel assay for measuring the titer of
anionic CPS. The phase separation assay requires 130 L of sam-
ple and is capable of measuring 96 samples in less than 1 h. A
microplate desalting step is integral to the assay and helps mini-
mize assay interference. The assay has been shown to be robust:
across a pH range of 3–8.75, with samples containing up to (at
least) 400 mM of NaCl, and in a diverse set of excipients and com-
plex in-process backgrounds. The most signiﬁcant interference
encountered was due to nucleic acids, for which a simple, effec-
tive enzymatic treatment was prescribed, assisting in the cleanup
of samples as complex as fermentation broth.
In our research, we  screened 16 unique capsular polysaccha-
rides, of which 13 were anionic. Every tested anionic CPS reacted
in this assay, independent of whether the acidic moiety was uronic
acid, sialic acid, or phosphate and whether the anion resided in the
CPS backbone or side chain. Neutral polysaccharides did not react
substantially in this assay (data not shown). These observations
suggest that the described method may  approach a universal titer
assay for anionic CPS.
The  described method improves the productivity of CPS titer
measurements by 30-fold. The capability to measure rapidly
microplate quantities of CPS samples, with little customization for
the underlying CPS chemistry has the potential to change the way
process development of CPS is conducted. In the future, this assay,
along with other advances in polysaccharide processing and ana-
lytics, will enable the HTPD of polysaccharides.
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